Cited by 228Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsPsychological Testing and Assessment

Cognitive Test Performance in Detecting, Staging, and Tracking Alzheimer's Disease

Locascio, J. J., Growdon, J. H., Corkin, S.·1995·Archives of Neurology

Abstract

OBJECTIVES: To identify the specific cognitive deficits that characterize Alzheimer's disease (AD) and determine which cognitive tests, or combination of tests, are best for detecting AD (ie, distinguishing patients with AD from normal control subjects), staging AD (ie, distinguishing different severities of dementia), and tracking disease progression. SUBJECTS: Patients with AD (n = 123) and normal control subjects (n = 60) of comparable age, education, and gender distribution. SETTING: Outpatient care. MEASURES: Ten cognitive tests of memory, language, visuospatial abilities, and reasoning; the Information, Memory and Concentration subtest of the Blessed Dementia Scale, and the total score on an activities of daily living questionnaire. DESIGN: Patients with AD were tested every 6 to 24 months over a span of up to 5.5 years. RESULTS: Patients with AD were significantly inferior to normal control subjects on all cognitive tests. The scores of patients with AD worsened over time. Delayed recall of stories and figures showed sharp deterioration to an early floor, consistent with the finding that these tests discriminated patients with mild AD from normal control subjects well but were poor for staging. Confrontation naming, semantic fluency, and immediate recognition of geometric figures showed steady linear decline across time for patients with AD, consistent with these tests being found best for staging dementia severity. CONCLUSIONS: We postulate that the pathologic bases of impairment in delayed recall are atrophy of cholinergic ventral forebrain neurons and partial deafferentation of the hippocampus, both of which occur early in the course of AD. Worsening language and visuospatial abilities likely reflect progressive loss of neocortical neurons and their connections.

Integrity signals

Registry

Crossref · 10.1001/archneur.1995.00540350081020

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The net result of multiple lesions in memory-related structures accounts for the impairment in explicit memory function that occurs as an early symptom in AD.

    “and that the net result of these multiple lesions in memory-related structures accounts for the impairment in explicit memory function that occurs as an early symptom in AD (Locascio et al., 1995).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Locascio, J. J., Growdon, J. H., & Corkin, S.
Affiliations
Massachusetts Institute of Technology (US)
Venue
Archives of Neurology
Published
1995-11-01
Volume
52
Issue
11
Pages
1087-1099
ISSN
0003-9942 (ISSN-L)
OpenAlex
W2011315628
Cited by
228
References
5
Citations by year
2026: 2 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 6 · 2019: 6 · 2018: 2 · 2017: 9 · 2016: 7 · 2015: 5 · 2014: 11 · 2013: 13 · 2012: 17
FWCI
3.78
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r37ag006605-08)
  • National Institute on Aging (AG06605, P50AG005134, AG 05134, 5R37AG06605)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Keywords
Alzheimer's disease, cognitive impairment, dementia staging, disease progression, delayed recall, confrontation naming, semantic fluency, visuospatial ability, language impairment, hippocampal atrophy, cholinergic neuron loss, activities of daily living
MeSH terms
Aged, Alzheimer Disease, Cognition, Female, Humans, Male, Memory, Neuropsychological Tests, Spatial Behavior, Visual Perception, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review